Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Moleculin Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MBRX.
You can purchase shares of Moleculin Biotech (NASDAQ:MBRX) through any online brokerage.
Other companies in Moleculin Biotech’s space includes: Immuron (NASDAQ:IMRN), Intensity Therapeutics (NASDAQ:INTS), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Sensei Biotherapeutics (NASDAQ:SNSE) and Genprex (NASDAQ:GNPX).
Moleculin Biotech has a consensus price target of $12.20.
The stock price for Moleculin Biotech (NASDAQ: MBRX) is $0.2677 last updated June 20, 2025 at 7:54 PM EDT.
There are no upcoming dividends for Moleculin Biotech.
Moleculin Biotech’s Q2 earnings are confirmed for Wednesday, August 13, 2025.
There is no upcoming split for Moleculin Biotech.
Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.